Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors.
Raf/MEK/ERK and phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) cascades are key signalling pathways interacting with each other to regulate cell growth and tumourigenesis. We have previously shown B-Raf and Akt overexpression and/or overactivation in pituitary adenomas...
Hlavní autoři: | Dworakowska, D, Wlodek, E, Leontiou, C, Igreja, S, Cakir, M, Teng, M, Prodromou, N, Góth, M, Grozinsky-Glasberg, S, Gueorguiev, M, Kola, B, Korbonits, M, Grossman, AB |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
2009
|
Podobné jednotky
-
The role of somatostatin analogues in the treatment of neuroendocrine tumours.
Autor: Grozinsky-Glasberg, S, a další
Vydáno: (2008) -
The pathology of pituitary adenomas from a clinical perspective.
Autor: Dworakowska, D, a další
Vydáno: (2011) -
Novel molecular aspects of pituitary adenomas.
Autor: Hubina, E, a další
Vydáno: (2005) -
Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy
Autor: Ufuk Degirmenci, a další
Vydáno: (2020-01-01) -
The pathophysiology of pituitary adenomas.
Autor: Dworakowska, D, a další
Vydáno: (2009)